Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 5Cyclophosphamide 5fludarabine 4Radiotherapy 4Irinotecan 4Mitomycin 3Interleukin-12 Subunit p35 3Fluorouracil 3Capecitabine 3Trastuzumab 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Erlotinib Hydrochloride 2Cetuximab 2Carboplatin 2tipifarnib 1tempol 1prexasertib 1oncogene protein E7, Human papillomavirus type 16 1entinostat 1Vorinostat 1Vaccines 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Papillomavirus Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Anus Neoplasms × E6 protein, Human papillomavirus type 16 × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡